Purchases and Sales Made in Q3 2023 in Biondvax Pharmaceuticals Ltd. (BVXVZZZZ)
This table provides information about the institutional ownership of Biondvax Pharmaceuticals Ltd. (BVXVZZZZ) during Q3 2023. The information is specifically focused on institutions that hold shares of BIONDVAX PHARMACEUTICALS LTD. .
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
362KNew |
N/A
|
362K
$0
|
|
Nov 14, 2023
Q3 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
BUY
|
- |
54K+ 28.3% |
N/A
|
245K
$0
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
BUY
|
- |
518+ 169.28% |
N/A
|
824
$0
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
100+ 4.58% |
N/A
|
2.28K
$0
|
|
Nov 09, 2023
Q3 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
50+ 1.43% |
N/A
|
3.55K
$0
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
7New |
N/A
|
7
$0
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|